| Drug Name: | Oxybutynin (5633-20-5) |
|---|---|
| PubChem ID: | 4634 |
| SMILES: | CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O |
| InchiKey: | XIQVNETUBQGFHX-UHFFFAOYSA-N |
| Therapeutic Category: | Autonomic Agents, Cholinergic Agents, Cholinergic Antagonists, Muscarinic Antagonists, Neurotransmitter Agents, Parasympatholytics, Peripheral Nervous System Agents, Urological Agents |
| Molecular Weight (dalton) | : | 357.494 |
| LogP | : | 3.3429 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 49.77 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Carbamazepine (298-46-4) | Nystagmus | Synergistic | due to the inhibition by oxybutynin of the cytochrome P450 isoenzyme CYP3A4-mediated metabolism of carbamazepine | Carbamazepine toxicity following Oxybutynin and Dantrolene administration: a case report |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category